Skip to main content

06-12-2018 | Empagliflozin | Article

Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: A randomized controlled trial (E-LIFT trial)

Kuchay MS et al. Diabetes Care 2018: dc180165. doi: 10.2337/dc18-0165

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.

Image Credits